These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30321331)

  • 1. An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study.
    Muñiz Pedrogo DA; Chen J; Hillmann B; Jeraldo P; Al-Ghalith G; Taneja V; Davis JM; Knights D; Nelson H; Faubion WA; Raffals L; Kashyap PC
    Inflamm Bowel Dis; 2019 Apr; 25(5):902-913. PubMed ID: 30321331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.
    Breban M; Tap J; Leboime A; Said-Nahal R; Langella P; Chiocchia G; Furet JP; Sokol H
    Ann Rheum Dis; 2017 Sep; 76(9):1614-1622. PubMed ID: 28606969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis.
    Chen J; Wright K; Davis JM; Jeraldo P; Marietta EV; Murray J; Nelson H; Matteson EL; Taneja V
    Genome Med; 2016 Apr; 8(1):43. PubMed ID: 27102666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
    Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
    Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
    Forbes JD; Chen CY; Knox NC; Marrie RA; El-Gabalawy H; de Kievit T; Alfa M; Bernstein CN; Van Domselaar G
    Microbiome; 2018 Dec; 6(1):221. PubMed ID: 30545401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host Genetic and Gut Microbial Signatures in Familial Inflammatory Bowel Disease.
    Park YM; Ha E; Gu KN; Shin GY; Lee CK; Kim K; Kim HJ
    Clin Transl Gastroenterol; 2020 Jul; 11(7):e00213. PubMed ID: 32764209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
    Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
    World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease.
    Malham M; Lilje B; Houen G; Winther K; Andersen PS; Jakobsen C
    Scand J Gastroenterol; 2019 Aug; 54(8):969-975. PubMed ID: 31329473
    [No Abstract]   [Full Text] [Related]  

  • 9. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
    World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease.
    Hertz S; Anderson JM; Nielsen HL; Schachtschneider C; McCauley KE; Özçam M; Larsen L; Lynch SV; Nielsen H
    Ann Med; 2024 Dec; 56(1):2338244. PubMed ID: 38648495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.
    Chehoud C; Albenberg LG; Judge C; Hoffmann C; Grunberg S; Bittinger K; Baldassano RN; Lewis JD; Bushman FD; Wu GD
    Inflamm Bowel Dis; 2015 Aug; 21(8):1948-56. PubMed ID: 26083617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
    Huh JW; Roh TY
    BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.
    Salem F; Kindt N; Marchesi JR; Netter P; Lopez A; Kokten T; Danese S; Jouzeau JY; Peyrin-Biroulet L; Moulin D
    United European Gastroenterol J; 2019 Oct; 7(8):1008-1032. PubMed ID: 31662859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.
    Teofani A; Marafini I; Laudisi F; Pietrucci D; Salvatori S; Unida V; Biocca S; Monteleone G; Desideri A
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiotic signatures and diagnostic potential of gut microbial markers for inflammatory bowel disease in Korean population.
    Kim HS; Oh SJ; Kim BK; Kim JE; Kim BH; Park YK; Yang BG; Lee JY; Bae JW; Lee CK
    Sci Rep; 2024 Oct; 14(1):23701. PubMed ID: 39390011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients.
    Yilmaz B; Spalinger MR; Biedermann L; Franc Y; Fournier N; Rossel JB; Juillerat P; Rogler G; Macpherson AJ; Scharl M
    PLoS One; 2018; 13(7):e0199664. PubMed ID: 29965986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Microbial Dysbiosis Index and Intestinal Microbiota-Associated Markers as Tools of Precision Medicine in Inflammatory Bowel Disease Paediatric Patients.
    Toto F; Marangelo C; Scanu M; De Angelis P; Isoldi S; Abreu MT; Cucchiara S; Stronati L; Del Chierico F; Putignani L
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.
    Scher JU; Ubeda C; Artacho A; Attur M; Isaac S; Reddy SM; Marmon S; Neimann A; Brusca S; Patel T; Manasson J; Pamer EG; Littman DR; Abramson SB
    Arthritis Rheumatol; 2015 Jan; 67(1):128-39. PubMed ID: 25319745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.